Tag : Myelofibrosis

Gastroenterology

Popular cancer drug linked to weight gain and increased systolic blood pressure

Newsemia
A popular cancer drug is associated with significant weight gain and increased systolic blood pressure, researchers from the Icahn School of Medicine at Mount Sinai...
Latest News

FDA approves first drug for blood disorder myelofibrosis since 2011

Newsemia
The agency said Friday that it had approved Celgene’s Inrebic (fedratinib), the first new drug approved for the disease – a type of rare blood...
Pharma / Biotech

Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib.

Newsemia
Related Articles Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib. Leuk Res. 2019 Feb 28;79:38-44 Authors: Gerds...
Latest News

Global Myelofibrosis Therapeutics Market 2018-2022| High Off-Label Prescription to Boost Demand | Technavio

Newsemia
LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/MyelofibrosisTherapeutics?src=hash" target="_blank"gt;#MyelofibrosisTherapeuticslt;/agt;–The global myelofibrosis therapeutics market is expected to post a CAGR of over 7% during 2018-2022, according to Technavio's latest market research....

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy